The ABCs of LTX for BAC

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 1, 2003, Pages 20-22

  Egan, Thomas M ^a,b   Detterbeck, Frank C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE SEVERITY; EDITORIAL; HEALTH CARE POLICY; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG TRANSPLANTATION; LYMPH NODE METASTASIS; LYMPHANGIOMATOSIS; MALIGNANT TRANSFORMATION; ORGAN DONOR; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TUMOR CELL;

EID: 0037248376     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.146     Document Type: Editorial

References (12)

1. UNOS. 2000 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data: 1990-1999: US Department of Health and Human Services, Rockville (MD); UNOS, Richmond (VA); 2001.
2. International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med. 1998;158:335-9.
3. Zorn GL Jr, McGiffin DC, Young KR Jr, Alexander CB, Weill D, Kirklin JK. Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 2003;125:45-8.
4. Johnson B, Duncan S, Ohori N, Paradis I, Yousem S, Grgurich W, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148:1373-7.
5. Nine JS, Yousem SA, Paradis IL, Keenan R. Griffith BP. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant. 1994;13:714-9.
6. Egan TM, Bennett LE, Garrity ER, Grover FL, Ring WS, Robbins RC, et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis (abstract). J Heart Lung Transplant. 2001;20:242.
7. Egan TM, Bennett LE, Garrity ER, Grover FL, Ring S, Robbins RC, et al. Are there predictors of death at the time of listing for lung transplant? (abstract). J Heart Lung Transplant. 2002;21:154.
8. Garver R, Zorn G, Wu X, McGiffin D, Young K, Pinkard N. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med. 1999;340:1071-4.
9. Detterbeck F, Jones D, Funkhouser W Jr. Bronchioloalveolar carcinoma. In: Detterbeck F, Rivera M, Socinski M, Rosenman J, editors. Diganosis and treatment of lung cancer: an evidence-based guide for the practicing clinician. Philadelphia: WB Saunders; 2001. p. 394-407.
10. Weber J, May P. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989;44:388-96.
11. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol. 2000;53:666-72.
12. Egan TM, Lambert CJ Jr, Reddick RL, Ulicny KS Jr. Keagy BA, Wilcox BR. A strategy to increase the donor pool: the use of cadaver lungs for transplantation. Ann Thorac Surg. 1991;52:1113-21.